Inhibition of hepatitis B virus DNA replication by imino sugars without the inhibition of the DNA polymerase: therapeutic implications.
about
Glycomic characterization of prostate-specific antigen and prostatic acid phosphatase in prostate cancer and benign disease seminal plasma fluidsAntiviral effects of an iminosugar derivative on flavivirus infectionsA heteroaryldihydropyrimidine activates and can misdirect hepatitis B virus capsid assemblyStructure-activity relationship of a new class of anti-hepatitis B virus agents.Strategies to eliminate HBV infection.Evolving therapies for the treatment of chronic hepatitis B virus infection.Iminosugars as possible broad spectrum anti hepatitis virus agents: the glucovirs and alkovirs.Matrix assisted laser desorption ionization imaging mass spectrometry workflow for spatial profiling analysis of N-linked glycan expression in tissuesN-arylated-lactam-type iminosugars as new immunosuppressive agents: discovery, optimization, and biological evaluation.Effects of interferon, ribavirin, and iminosugar derivatives on cells persistently infected with noncytopathic bovine viral diarrhea virus.Iminosugars Inhibit Dengue Virus Production via Inhibition of ER Alpha-Glucosidases--Not Glycolipid Processing Enzymes.The alkylated imino sugar, n-(n-Nonyl)-deoxygalactonojirimycin, reduces the amount of hepatitis B virus nucleocapsid in tissue culture.Intrinsic hepatocyte dedifferentiation is accompanied by upregulation of mesenchymal markers, protein sialylation and core alpha 1,6 linked fucosylationImino sugar glucosidase inhibitors as broadly active anti-filovirus agentsIncreased bisecting N-acetylglucosamine and decreased branched chain glycans of N-linked glycoproteins in expressed prostatic secretions associated with prostate cancer progression.HBV life cycle and novel drug targets.Metathesis access to monocyclic iminocyclitol-based therapeutic agents.Antihepatitis B therapy: a review of current medications and novel small molecule inhibitors.Treatment of hepatitis B virus: an update.Design, synthesis, and biological evaluation of N-alkylated deoxynojirimycin (DNJ) derivatives for the treatment of dengue virus infection.Antiviral profiles of novel iminocyclitol compounds against bovine viral diarrhea virus, West Nile virus, dengue virus and hepatitis B virus.alpha-Glucosidase inhibitors have a prolonged antiviral effect against hepatitis B virus through the sustained inhibition of the large and middle envelope glycoproteins.Novel five-membered iminocyclitol derivatives as selective and potent glycosidase inhibitors: new structures for antivirals and osteoarthritis.alpha-Galactosylceramide and novel synthetic glycolipids directly induce the innate host defense pathway and have direct activity against hepatitis B and C viruses.Imino sugars that are less toxic but more potent as antivirals, in vitro, compared with N-n-nonyl DNJ.
P2860
Q24644593-DCB7ECB1-9AC4-4B58-A817-FA8B74C66BEEQ27472863-4E78CB03-05BD-4FE0-A189-F2D434E3CF47Q33852071-F73C0F02-3F80-4E1E-9475-67913D171769Q34251931-C6CB3FC5-375B-42D4-8B3F-82736A8969DAQ34308129-C66F3F98-3EC0-4EB4-A162-D14F1E06940AQ34519117-7F4B35D1-ADB8-476A-B2CE-43B33E60C846Q34644755-C5BCA61F-90FF-4D23-ABBB-D35C67C18718Q34992443-7943E879-D0C2-4042-AA7A-DBFB0C22E63CQ35139331-F7F0C9C2-294A-4AFF-809B-D5E1760BA518Q35548601-2FA6EB54-F818-4AE5-B44B-1BD1EBFC2F1DQ35956223-FDBDDA6A-C05D-47BF-8D44-E5E9BB8002A8Q36890738-AB801F74-A62A-441B-BF78-E0C69635B76FQ37027426-8ED2172D-E358-4B8C-BC18-10636BEB3058Q37584342-A1A93B15-C216-4B4B-9101-63ED8926D5B6Q37672628-4AB549D9-A627-478C-8306-BE0707C748D3Q37864117-390130E5-3C55-4DED-96F1-3FF5367202C8Q37909033-17B7A907-4963-4CCC-A218-636DBB84E7CDQ38151881-A0BB1D7C-2EE7-4A09-9E76-6487B5B1588FQ38794446-B3779C57-A92B-409C-BD1C-B4861F105CF9Q39328622-19792035-F82C-43CA-A893-C646AED821C7Q40160028-6E29A516-A420-4356-89A9-31C9BEDD6798Q40193811-6710A260-3CB5-4561-92BE-81B7D187510DQ40332920-D7905566-CC5A-44E8-A2D2-10940EEC7A33Q40553724-24C3A68D-A350-43D7-9C5A-5F4ACAD42480Q40664872-AD04093A-4C32-495F-AA56-4736DDE75C05
P2860
Inhibition of hepatitis B virus DNA replication by imino sugars without the inhibition of the DNA polymerase: therapeutic implications.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Inhibition of hepatitis B viru ...... ase: therapeutic implications.
@en
type
label
Inhibition of hepatitis B viru ...... ase: therapeutic implications.
@en
prefLabel
Inhibition of hepatitis B viru ...... ase: therapeutic implications.
@en
P2093
P356
P1433
P1476
Inhibition of hepatitis B viru ...... ase: therapeutic implications.
@en
P2093
Carrouée S
P304
P356
10.1053/JHEP.2001.25103
P407
P577
2001-06-01T00:00:00Z